Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Epithelial-mesenchymal transition (EMT) describes a series of rapid changes in cellular phenotype. During EMT, epithelial cells down-modulate cell-cell adhesion structures, alter their polarity, reorganize their cytoskeleton, and become isolated, motile, and resistant to anoikis. The term EMT is often applied to distinct biological events as if it were a single conserved process, but in fact EMT-related processes can vary in intensity from a transient loss of cell polarity to the total cellular reprogramming, as found by transcriptional analysis. Based on clinical observations, it is more appropriate in most cases to describe the emergence of an EMT-like phenotype during tumor progression. Although EMT implies complete trans-differentiation, EMT-like emphasizes the intermediary phenotype associated with tumor cell renewal and adaptation to specific microenvironments. Here, we categorize the various EMT-like phenotypes found in human carcinomas that, depending on the tumor type, may or not represent analogous stages in tumor progression. We based these categories on the global tumor phenotype. The tumor microenvironment, which is associated with stromal reactions, hypoxia, paucity of nutrients, impaired differentiation, and activation of various EMT-associated pathways, modulates overall tumor phenotype and leads to tumor heterogeneity.
Alves,
Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin.
2007, Pubmed
Alves,
Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin.
2007,
Pubmed
Arias,
Cancer cell: using inflammation to invade the host.
2007,
Pubmed
Barak,
Clinical utility of cytokeratins as tumor markers.
2004,
Pubmed
Barrallo-Gimeno,
The Snail genes as inducers of cell movement and survival: implications in development and cancer.
2005,
Pubmed
Batlle,
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.
2000,
Pubmed
Baum,
Transitions between epithelial and mesenchymal states in development and disease.
2008,
Pubmed
Baumann,
CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis.
2005,
Pubmed
Beach,
Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.
2008,
Pubmed
Becker,
Analysis of the E-cadherin repressor Snail in primary human cancers.
2007,
Pubmed
Berx,
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
2007,
Pubmed
Biernat,
Carcinosarcoma of the skin. Case report and literature review.
1996,
Pubmed
Bolender,
Epithelial-mesenchymal transformation in chick atrioventricular cushion morphogenesis.
1979,
Pubmed
Bolós,
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.
2003,
Pubmed
Boyer,
Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells.
1989,
Pubmed
Brabletz,
Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.
2005,
Pubmed
Brakebusch,
beta 1 integrin function in vivo: adhesion, migration and more.
2005,
Pubmed
Côme,
Snail and slug play distinct roles during breast carcinoma progression.
2006,
Pubmed
Dacic,
Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping.
2002,
Pubmed
Daniel,
Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth.
1995,
Pubmed
Derksen,
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.
2006,
Pubmed
Dow,
Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis.
2007,
Pubmed
Evans,
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.
2007,
Pubmed
Fujii,
Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.
2000,
Pubmed
Fukino,
Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.
2004,
Pubmed
Greenburg,
Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells.
1982,
Pubmed
Greenburg,
Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchyme-like cells in vitro.
1986,
Pubmed
Halachmi,
Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin.
2000,
Pubmed
Hamilton,
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
2007,
Pubmed
Harris,
Hypoxia--a key regulatory factor in tumour growth.
2002,
Pubmed
Howe,
Mutations in the SMAD4/DPC4 gene in juvenile polyposis.
1998,
Pubmed
Hu,
Association of Vimentin overexpression and hepatocellular carcinoma metastasis.
2004,
Pubmed
Imai,
Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.
2003,
Pubmed
Kajita,
Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress.
2004,
Pubmed
Lee,
The epithelial-mesenchymal transition: new insights in signaling, development, and disease.
2006,
Pubmed
Li,
Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells.
1992,
Pubmed
Mackenzie,
Found in translation: A new player in EMT.
2006,
Pubmed
Mani,
The epithelial-mesenchymal transition generates cells with properties of stem cells.
2008,
Pubmed
McCarthy,
Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.
2004,
Pubmed
Min,
The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
2007,
Pubmed
Moinfar,
Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
2000,
Pubmed
Moll,
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
1993,
Pubmed
Moustakas,
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.
2007,
Pubmed
Ngan,
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer.
2007,
Pubmed
Peinado,
A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.
2005,
Pubmed
Perl,
A causal role for E-cadherin in the transition from adenoma to carcinoma.
1998,
Pubmed
Pérez-Mancera,
SLUG in cancer development.
2005,
Pubmed
Savagner,
The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition.
1997,
Pubmed
Savagner,
Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes.
2005,
Pubmed
Savagner,
Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.
2001,
Pubmed
Stockinger,
E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity.
2001,
Pubmed
Storci,
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.
2008,
Pubmed
Tarin,
The fallacy of epithelial mesenchymal transition in neoplasia.
2005,
Pubmed
Thiery,
Complex networks orchestrate epithelial-mesenchymal transitions.
2006,
Pubmed
Thompson,
Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis.
1996,
Pubmed
Tlsty,
Tumor stroma and regulation of cancer development.
2006,
Pubmed
Uehara,
Expression of a human hepatocyte growth factor/scatter factor cDNA in MDCK epithelial cells influences cell morphology, motility, and anchorage-independent growth.
1992,
Pubmed
Valdés,
The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.
2002,
Pubmed
Waerner,
ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.
2006,
Pubmed
Weidner,
The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
1993,
Pubmed
Wu,
Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma.
2005,
Pubmed
Wyatt,
The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development.
2007,
Pubmed
Wyckoff,
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.
2007,
Pubmed
Yang,
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
2004,
Pubmed
Yang,
TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development.
2008,
Pubmed
Yoon,
CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
2007,
Pubmed
Zhang,
An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm.
2006,
Pubmed
,
Xenbase
